Evidence map›Paper›PMID 42343405›Full record

ArticleJournal of cardiothoracic surgery2026

Impact of a comprehensive healthy lifestyle score on a broad spectrum of cardiometabolic and related diseases and its incremental value for risk prediction based on the UK biobank database.

Xinyue Chen, Sen Han, Yating Chen, Sheng Yuan, Jining He, Zixiang Ye, Yanjun Song, Kefei Dou

Abstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinyue Chen *Cardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China.
Sen Han *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Oncology II, Peking University Cancer Hospital and Institute, Beijing, China.
Yating ChenBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sheng YuanCardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China.
Jining HeCardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China.
Zixiang YeCardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China.
Yanjun Song *Cardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China. camssongyanjun@163.com.
Kefei Dou *Cardiometabolic Medicine Center, Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, BeijingBeijing, 100037, China. drdoukefei@126.com.ORCID https://orcid.org/0000-0002-8372-6338

Funding

National High Level Hospital Clinical Research Funding 2022-GSP-QN-06, 2023-GSP-GG-02, 2023-GSP-QN-17, 2023-GSP-QN-34, 2023-GSP-RC-05Noncommunicable Chronic Diseases-National Science and Technology Major Project 2025ZD0548200Science Foundation of Peking University Cancer Hospital JC202508
6 · The paper itself

Abstract

backgroundCardiometabolic and related diseases (CMDs) represent a major global disease burden. While traditional risk factors are well-established, the role of lifestyle factors in primary prevention has not been sufficiently studied.

methodsThis study analyzed data from 148,155 participants in the UK Biobank without baseline CMDs. Cox proportional hazards models were used to assess the impact of healthy lifestyle factors (non-current smoking, non-excessive drinking, regular physical activity, healthy diet, and healthy sleep) on 11 types of CMDs (coronary heart disease, type 2 diabetes, atrial fibrillation, hypertension, stroke, heart failure, Alzheimer's disease, non-alcoholic fatty liver disease, valvular heart disease, cardiomyopathy, and pulmonary hypertension). Participants were categorized into four groups based on weighted lifestyle scores. Improvements in predictive models after incorporating lifestyle factors were evaluated.

resultsMost individual healthy lifestyle factors were associated with a lower risk of CMDs, while regular physical activity was not independently associated with composite CMD risk in the fully adjusted model; healthy sleep contributed the largest weight to the composite lifestyle score (β = 0.342). Adhering to a healthier lifestyle demonstrated a significant and dose-response association with a reduced risk of composite CMDs. In the fully adjusted model, compared to the "very unhealthy" group, the "very healthy" group exhibited a significantly lower risk of developing CMDs (HR: 0.70, 95% CI: 0.67-0.74). Similar inverse associations were observed across several individual CMDs, with the strongest association observed for pulmonary hypertension (HR: 0.34, 95% CI: 0.24-0.50). Incorporating the lifestyle score into traditional risk models was associated with modest improvement in predictive performance. The findings were generally consistent across subgroups and sensitivity analyses.

conclusionsThese findings suggest that adherence to a comprehensive healthy lifestyle, including adequate sleep, is associated with reduced risk of various CMDs and may improve risk stratification. The particularly strong association observed for pulmonary hypertension also supports further investigation of lifestyle patterns across a broader range of cardiometabolic and related conditions.

trial registrationNot applicable.

Indexed as

Cardiovascular DiseasesHealthy LifestyleAgedBiological Specimen BanksDatabases, FactualFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsUK BiobankUnited KingdomCardiometabolic diseasesHealthy lifestylePrimary preventionRisk stratification

Identifiers

PMID42343405
PMCPMC13551960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.